Can Popular Weight-Loss Drugs Protect Against Obesity-Related Cancers?June 4, 2025CancerObesityOncologyDiabetes
Statin-Induced Necrotizing Autoimmune Myopathy in a Patient With Complex Diabetes ManagementApril 7, 2025Diabetes
GLP-1s Have Real-World Benefits and Risks In Large Scale VA StudyJanuary 27, 2025DiabetesMental Health
Satisfaction With Department of Veterans Affairs Prosthetics and Support Services as Reported by Women and Men VeteransNovember 20, 2024Diabetes
Multidisciplinary Amputation Prevention at the DeBakey VA Hospital: Our First DecadeNovember 8, 2024Diabetes
Evaluating Use of Empagliflozin for Diabetes Management in Veterans With Chronic Kidney DiseaseNovember 6, 2024DiabetesNephrology
GLP-1 RAs Reduce Early-Onset CRC Risk in Patients With Type 2 DiabetesOctober 31, 2024Colorectal CancerDiabetesOncologyColon and Rectal
The Impact of a Metformin Recall on Patient Hemoglobin A1c Levels at a VA NetworkOctober 30, 2024Diabetes
Continuous Glucose Monitoring vs Fingerstick Monitoring for Hemoglobin A1c Control in VeteransOctober 29, 2024Diabetes
Genitourinary Symptoms in Men: Canaries in the Coal Mine for Underlying Chronic DiseaseSeptember 13, 2024DiabetesObesity
Signal of Suicide Ideation With GLP-1 RA Semaglutide, but Experts Urge CautionAugust 26, 2024DiabetesObesityDepressionMental HealthSleep Medicine
